AUA 2018 take-homes highlight guidelines, opioids, robotics

July 11, 2018

Three new clinical guidelines, potentially practice-changing advances in robotics and artificial intelligence, and research on hot-button public health issues such as opioid abuse were among many highlights of the AUA annual meeting in San Francisco.

Three new clinical guidelines, potentially practice-changing advances in robotics and artificial intelligence, and research on hot-button public health issues such as opioid abuse were among many highlights of the AUA annual meeting in San Francisco.

Despite being a day shorter than previous meetings, this year’s event felt no less packed with excellent science and a spirit of camaraderie among attendees. Health policy and practice management in a changing health care landscape, the impact of FDA actions on testosterone replacement and sling surgery, the pros and cons of prostate cancer screening and surveillance, and a new focus on care of transgender patients were also high-interest topics.

In this article, Urology Times recaps AUA 2018 with our report of the meeting’s annual take-home messages. Messages have been edited for space, and some topics are covered exclusively online. 

Click on a topic below to view the take-home messages for that area, and check back for more topics that will be added soon.

Prostate Cancer

Endourology/Stones

BPH/LUTS

Bladder Cancer

Kidney Cancer

Penile/Urethral Cancer

Imaging

Outcomes

Minimally Invasive Surgery

Sexual Dysfunction

Transplantation

Infertility/andrology

Basic Science (Malignant)

Basic Science (Benign)

Pediatric Urology

Female Urology

Trauma/Reconstruction

Quality Improvement and Patient Safety